Predict your next investment

Corporation
HEALTHCARE | Drug Development
ocugen.com

See what CB Insights has to offer

Founded Year

2013

Stage

Loan | IPO

Total Raised

$19.73M

About Ocugen

Ocugen is a Malvern, Pennsylvania-based ophthalmology company developing a clinical pipeline of therapies that address rare and underserved ocular disorders.

Ocugen Headquarter Location

5 Great Valley Parkway Suite #160

Malvern, Pennsylvania, 19355,

United States

484-328-4701

Latest Ocugen News

Gen Z investors shift focus from 'meme-stocks' to the 'metaverse,' report shows

Jan 14, 2022

FILE PHOTO: Visitors are pictured in front of an immersive art installation titled "Machine Hallucinations — Space: Metaverse" by media artist Refik Anadol, which will be converted into NFT and auctioned online at Sotheby's, at the Digital Art Fair, in Hong Kong, China September 30, 2021. REUTERS/Tyrone Siu NEW YORK (Reuters) - Enthusiasm around "meme stocks" has eased for young investors a year on from the GameStop Corp trading frenzy, with Gen Z's attention shifting to companies in areas like electric vehicles and the "metaverse," according to a report released on Friday. The top stock holding among the Gen Z cohort - people born after 1996 - in the fourth quarter was Tesla Inc, according to the quarterly investor outlook from Apex Fintech Solutions, which provides custody and clearing services for brokers like SoFi, Stash, WeBull, and Goldman Sachs Group's Marcus. AMC Entertainment slipped from the No. 1 spot in the top 100 ranking of stocks for the first time in several quarters, to No. 3, said the report, which analyzed more than 1 million Gen Z accounts held by Apex's clearing arm. GameStop, which retail investors piled in to last January in a social media-fueled attempt to punish short sellers, dropped five spots to No. 11, the report showed. Meme stocks with less mainstream buzz fell more, with e-commerce platform Wish's owner, ContextLogic, down 35 spots at No. 56 and biopharmaceutical company Ocugen Inc dropping 41 spots to No. 91. Electric vehicle startup Rivian Automotive Inc, which went public in November, debuted at No. 44, while Chinese EV maker NIO held the No. 8 spot and Ford Motor Co was No. 19. Shares of Facebook parent Meta Platforms Inc rose a couple of notches to No. 12, while Roblox rose 36 spots to No. 36. "There's a lot more interest in metaverse," Apex Chief Executive Officer Bill Capuzzi said in an interview. "As more NFT companies become public, we'll probably see them move in to the top 100." The metaverse generally refers to shared virtual world environments which people can access via the internet, often making use of virtual reality or augmented reality. Payment companies were also popular with young investors, with Paypal Inc jumping 9 spots from the third quarter to No. 19, while Block, formerly called Square, was steady at No. 25. (Reporting by John McCrank in New York; Editing by Matthew Lewis) Article type: metered

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Ocugen

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Ocugen is included in 1 Expert Collection, including Biopharma Tech.

B

Biopharma Tech

15,532 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

Ocugen Patents

Ocugen has filed 8 patents.

The 3 most popular patent topics include:

  • Autoimmune diseases
  • Diseases of the eye and adnexa
  • Amines
patents chart

Application Date

Grant Date

Title

Related Topics

Status

1/30/2018

8/25/2020

Beta blockers, Glucocorticoids, Pregnanes, Fluoroarenes, Amines

Grant

Application Date

1/30/2018

Grant Date

8/25/2020

Title

Related Topics

Beta blockers, Glucocorticoids, Pregnanes, Fluoroarenes, Amines

Status

Grant

Ocugen Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Ocugen Rank

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.